Early changes preceding beta cell autoimmunity and type 1 diabetes
Description of the granted funding
Type 1 diabetes (T1D) is heterogeneous autoimmune disease that has high prevalence in developed countries. It has severe long-term complications and constitutes a significant challenge to the health care system. Our goal is to improve understanding of disease process by studying changes in immune cells during early stages of disease development. Further, we aim at discovering and validating these changes that could potentially be used to predict, diagnose and monitor T1D. We will combine expertise and methods from different disciplines including clinical research, cutting-edge experimental methods and computational systems biology. Our results are expected to increase understanding of the pathogenesis of human T1D and immune response early in the disease process. We expect to discover and validate candidate biomarkers that identify individuals with risk to develop T1D, which in turn will provide new opportunities for early prevention and treatment of the disease.
Show moreStarting year
2021
End year
2022
Granted funding
Funder
Research Council of Finland
Funding instrument
Postdoctoral Researcher
Other information
Funding decision number
340231
Fields of science
Genetics, developmental biology, physiology
Research fields
Perinnöllisyystiede
Identified topics
diabetes, medicine, metabolic diseases